Learn About Progressive Supranuclear Palsy Atypical

What are the alternative names for Progressive Supranuclear Palsy Atypical?
  • Atypical PSP
Save information for later
Sign Up
Who are the top Progressive Supranuclear Palsy Atypical Local Doctors?
AB
Dr. Adam L. Boxer
Neurology
Elite
Highly rated in
21
conditions
Neurology

Memory And Aging Center

San Francisco, CA 

Adam Boxer is a Neurologist in San Francisco, California. Dr. Boxer has been practicing medicine for over 24 years and is rated as an Elite doctor by MediFind in the treatment of Progressive Supranuclear Palsy Atypical. He is also highly rated in 21 other conditions, according to our data. His top areas of expertise are Frontotemporal Dementia, Progressive Supranuclear Palsy Atypical, Progressive Supranuclear Palsy, and Supranuclear Ophthalmoplegia. He is board certified in Neurology and licensed to treat patients in California.

View Profile
GH
Gunter U. Hoglinger
Elite
Highly rated in
18
conditions

German Center For Neurodegenerative Diseases

Hannover, NI, DE 

Gunter Hoglinger is in Hannover, Germany. Hoglinger is rated as an Elite expert by MediFind in the treatment of Progressive Supranuclear Palsy Atypical. They are also highly rated in 18 other conditions, according to our data. Their top areas of expertise are Supranuclear Ophthalmoplegia, Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, and Brown Syndrome.

View Profile
 
 
 
 
Learn about our expert tiers
Learn more
IL
Dr. Irene Litvan
Neurology
Elite
Highly rated in
25
conditions
Neurology

La Jolla 4510 Executive Dr

San Diego, CA 

Irene Litvan is a Neurologist in San Diego, California. Dr. Litvan has been practicing medicine for over 43 years and is rated as an Elite doctor by MediFind in the treatment of Progressive Supranuclear Palsy Atypical. She is also highly rated in 25 other conditions, according to our data. Her top areas of expertise are Parkinson's Disease, Supranuclear Ophthalmoplegia, Progressive Supranuclear Palsy, and Progressive Supranuclear Palsy Atypical. She is board certified in Neurology and licensed to treat patients in Kentucky. Dr. Litvan is currently accepting new patients.

View Profile
View All Doctors
What are the latest Progressive Supranuclear Palsy Atypical Clinical Trials?
Biomarkers in Neurodegenerative Diseases
Status: Recruiting
Start Date: October 9, 2019
View Trial
Summary: With the increase in life expectancy of our population due to advancement of medical diagnosis and treatments, the incidence of age dependent neurodegenerative diseases increased, including Alzheimer's disease (AD), parkinsonian syndromes (PS), small vessel disease (SVD) and motor neuron disease (MND). In spite of the progress of knowing the pathogenesis of various neurodegenerative diseases at mo...
Match to trials
Find the right clinical trials for you in under a minute
Get started
An Open Label, Single Center Study to Evaluate the Safety and Imaging Characteristics of [18F]PI-2620 as PET Radioligand for Imaging Tau Deposition in the Brains of Patients With Mild to Moderate Alzheimer's Disease (AD) and Patients With Progressive Supranuclear Palsy (PSP) After i.v. Application of [18F]PI-2620 With High and Low Specific Activity
Who is this study for: Patients with mild to moderate Alzheimer's disease and patients with progressive supranuclear palsy
Status: Recruiting
Start Date: November 12, 2020
Intervention Type: Drug
Phase: Phase 1
View Trial
Summary: This is an open-label study without randomisation. All eligible patients will receive two administrations of the investigational imaging agent [18F]PI-2620 at a radioactive dose of 185 MBq, one with high specific activity (≤ 5 µg tracer mass dose), another one with low specific activity (40-50 µg tracer mass dose).
View All Clinical Trials
What are the Latest Advances for Progressive Supranuclear Palsy Atypical?
Umbilical cord blood stem cells transplantation in a patient with severe progressive supranuclear palsy: a case report.
Condition: Severe Progressive Supranuclear Palsy
Journal: Journal of medical case reports
Treatment Used: Umbilical Cord Blood Stem Cells Transplantation
Number of Patients: 1
Published: November 30, 2021
View publication
Summary: The study researched the outcomes of an umbilical cord blood stem cells transplantation in a patient with severe progressive supranuclear palsy.
Deep learning reveals disease-specific signatures of white matter pathology in tauopathies.
Journal: Acta neuropathologica communications
Published: October 22, 2021
View publication
Summary: Deep learning reveals disease-specific signatures of white matter pathology in tauopathies.
Tired of the same old research?
Check Latest Advances
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.
Journal: The Lancet. Neurology
Published: August 21, 2021
View publication
Summary: Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.
View All Latest Advances